HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marçal Pastor-Anglada Selected Research

Nucleoside Transport Proteins (Nucleoside Transporter)

7/2012Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.
12/2008Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
8/2008Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.
1/2006Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer.
10/2003Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marçal Pastor-Anglada Research Topics

Disease

16Neoplasms (Cancer)
12/2021 - 10/2003
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2016 - 03/2003
6Infections
10/2016 - 02/2005
4Breast Neoplasms (Breast Cancer)
09/2012 - 01/2006
4Gestational Diabetes (Gestational Diabetes Mellitus)
04/2010 - 07/2005
4Adenocarcinoma
01/2009 - 10/2003
3Fibrosis (Cirrhosis)
11/2020 - 04/2012
3Leukemia
01/2020 - 03/2003
3Hypoxia (Hypoxemia)
10/2014 - 07/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2009 - 10/2003
3Hepatocellular Carcinoma (Hepatoma)
04/2006 - 04/2004
2Inflammation (Inflammations)
11/2020 - 04/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 08/2016
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2020
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2016 - 01/2013
2Virus Diseases (Viral Diseases)
01/2015 - 06/2010
2Acquired Immunodeficiency Syndrome (AIDS)
01/2015 - 06/2010
2Hematologic Neoplasms (Hematological Malignancy)
12/2011 - 03/2003
2Fetal Growth Retardation (Intrauterine Growth Retardation)
11/2011 - 07/2005
2Lipodystrophy
11/2010 - 01/2007
2Diabetes Mellitus
04/2010 - 06/2009
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1Fever (Fevers)
01/2019
1Acidosis
01/2019
1Cholangiocarcinoma
10/2017
1Crohn Disease (Crohn's Disease)
02/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2016
1Type 2 Diabetes Mellitus (MODY)
01/2016
1HIV Infections (HIV Infection)
01/2016
1Hepatitis
01/2015
1Chronic Hepatitis C
09/2014
1Proteinuria
01/2013
1Colonic Neoplasms (Colon Cancer)
09/2012
1Contracture
01/2012
1Hypertrichosis
01/2012
1Histiocytosis
01/2012
1Histiocytosis with joint contractures and sensorineural deafness
01/2012
1Acute Promyelocytic Leukemia
04/2010

Drug/Important Bio-Agent (IBA)

24NucleosidesIBA
01/2020 - 03/2003
15Pharmaceutical PreparationsIBA
10/2017 - 03/2003
14Proteins (Proteins, Gene)FDA Link
12/2021 - 03/2003
9Messenger RNA (mRNA)IBA
01/2020 - 07/2003
8Adenosine (Adenocard)FDA LinkGeneric
01/2016 - 08/2004
6GemcitabineFDA Link
09/2012 - 10/2003
5Equilibrative Nucleoside Transporter 1IBA
08/2016 - 07/2005
5Nucleoside Transport Proteins (Nucleoside Transporter)IBA
07/2012 - 10/2003
4fludarabineIBA
06/2012 - 03/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020 - 08/2016
3EnzymesIBA
01/2020 - 02/2005
3UridineIBA
01/2019 - 11/2010
3CytokinesIBA
10/2014 - 01/2007
3adenosine transporterIBA
09/2013 - 04/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2010 - 08/2006
3Protein Isoforms (Isoforms)IBA
06/2008 - 10/2003
2Interleukin-6 (Interleukin 6)IBA
10/2014 - 10/2004
2Oxygen (Dioxygen)IBA
10/2014 - 07/2005
2Adenosine Triphosphate (ATP)IBA
09/2013 - 04/2006
2doxifluridineIBA
09/2012 - 12/2006
2Capecitabine (Xeloda)FDA Link
09/2012 - 12/2006
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2012 - 04/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2007 - 10/2004
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
08/2006 - 07/2005
2Bile Acids and Salts (Bile Acids)IBA
04/2006 - 01/2003
1PyrimidinesIBA
12/2021
1MicroRNAs (MicroRNA)IBA
12/2021
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020
1fms-Like Tyrosine Kinase 3IBA
01/2020
1NucleotidasesIBA
01/2020
1NucleotidesIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2019
1Raltegravir PotassiumFDA Link
10/2016
1multidrug resistance-associated protein 1IBA
10/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2016
1idelalisibIBA
02/2016
1Bendamustine HydrochlorideFDA Link
02/2016
1ibrutinibIBA
02/2016
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
02/2016
1Lamivudine (Epivir)FDA Link
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Peptides (Polypeptides)IBA
01/2016
1Interleukin-10 (Interleukin 10)IBA
10/2014
1Equilibrative-Nucleoside Transporter 2IBA
10/2014
1Serotonin (5 Hydroxytryptamine)IBA
10/2014
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2014
1Interleukin-8 (Interleukin 8)IBA
10/2014
1Antiviral Agents (Antivirals)IBA
09/2014
1Ribavirin (Virazole)FDA LinkGeneric
09/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1Aquaporin 3IBA
09/2012
1AquaglyceroporinsIBA
09/2012
1Insulin (Novolin)FDA Link
01/2012
1NicotineFDA Link
11/2011
1Caffeine (No Doz)FDA LinkGeneric
11/2011
1Transcription Factor CHOPIBA
04/2010
1CCAAT-Enhancer-Binding Protein-alphaIBA
04/2010

Therapy/Procedure

6Drug Therapy (Chemotherapy)
10/2017 - 01/2005
4Therapeutics
01/2020 - 11/2010
2Highly Active Antiretroviral Therapy (HAART)
11/2010 - 01/2007